Sharma E I Hosp.

  • Market Cap: N/A
  • Industry: Healthcare Services
  • ISIN: INE465H01012
  • NSEID:
  • BSEID: 524548
INR
130.20
-11.55 (-8.15%)
BSENSE

Dec 26

BSE+NSE Vol: 1.27 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Who are in the management team of Sharma E I Hosp.?

06-Jun-2025

As of March 2018, the management team of Sharma E I Hosp. includes Shailendra Kumar Sharma (Managing Director), Karan Sharma, Maya Sharma (both Non Executive Directors), Subhash Chand Jain and Madhur Krishna Khaitan (both Non Executive Independent Directors), and Shiv Shankar Sharma (Company Secretary). Only Shailendra Kumar Sharma receives remuneration, which is Rs. 24.0 lacs.

As of March 2018, the management team of Sharma E I Hosp. includes the following individuals:<BR><BR>1. Shailendra Kumar Sharma - Managing Director<BR>2. Karan Sharma - Non Executive Director<BR>3. Maya Sharma - Non Executive Director<BR>4. Subhash Chand Jain - Non Executive Independent Director<BR>5. Madhur Krishna Khaitan - Non Executive Independent Director<BR>6. Shiv Shankar Sharma - Company Secretary cum Compliance Officer<BR><BR>Shailendra Kumar Sharma is the only member with a specified remuneration, which is Rs. 24.0 lacs. The other members do not receive remuneration.

Read More

When is the next results date for Sharma E I Hosp.?

06-Jun-2025

No Upcoming Board Meetings

Has Sharma E I Hosp. declared dividend?

06-Jun-2025

No Dividend History Available

Who are the peers of the Sharma E I Hosp.?

03-Jun-2025

No Peers Information Available

What is the technical trend for Sharma E I Hosp.?

09-Jun-2025

As of June 6, 2025, Sharma E I Hosp. shows a mildly bearish trend overall, influenced by daily moving averages and Bollinger Bands, despite a mildly bullish indication from the weekly MACD and Dow Theory.

As of 6 June 2025, the technical trend for Sharma E I Hosp. has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the daily moving averages are showing a mildly bearish trend. The Bollinger Bands on a weekly basis are bearish, and the KST is bearish as well. Dow Theory suggests a mildly bullish trend on the weekly timeframe, but there is no trend on the monthly. Overall, the current technical stance is mildly bearish, driven primarily by the daily moving averages and the Bollinger Bands.

Read More

What does Sharma E I Hosp. do?

17-Jul-2025

Sharma East India Hospitals & Medical Research Ltd operates a multi-specialty hospital in Jaipur, Rajasthan, providing healthcare services. As of March 2025, it reported net sales of 60 Cr and a net profit of 4 Cr.

Overview:<BR>Sharma East India Hospitals & Medical Research Ltd operates in the healthcare services industry, providing medical and healthcare services through its multi-specialty hospital.<BR><BR>History:<BR>The company was incorporated on November 16, 1989, and has been operating the 'Jaipur Hospital' in Lal Kothi, Jaipur, Rajasthan since its inception. The latest quarterly results reported are for March 2025.<BR><BR>Financial Snapshot:<BR>Net Sales: 60 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: 4 Cr (Quarterly Results - Mar 2025) <BR>Market cap: INR Cr (N/A)<BR><BR>Key Metrics:<BR>Industry: Healthcare Services <BR>Market cap: N/A <BR>Industry P/E: N/A <BR>Dividend Yield: 0.00% <BR>Debt Equity: 0.00 <BR>Return on Equity: 0.00% <BR>Price to Book: 0.00 <BR><BR>Contact Details:<BR>Address: Jaipur Hospitals Lal Kothi, Near SMS Stadium Tonk Road Jaipur Rajasthan : 302015 <BR>Tel: 91-141-2742266/2741465/2741465 <BR>Fax: 91-141-2742472 <BR>Email: jaipurhospital_lalkothi@rediffmail. <BR>Website: http://www.jaipurhospital.co.in

Read More

How big is Sharma E I Hosp.?

24-Jul-2025

As of 31st March, Sharma East India Hosp and Medical Research Ltd has an unavailable market capitalization. The latest financial metrics show net sales of 29.87 Cr and net profit of 1.25 Cr, with shareholder's funds at 11.23 Cr and total assets of 25.17 Cr.

As of 31st March, <BR><BR>Market Cap: Sharma East India Hosp and Medical Research Ltd has a market capitalization value that is not available, and therefore its market cap type cannot be determined.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 29.87 Cr, while the sum of Net Profit for the same period is 1.25 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period is the latest annual period ending in March 2024. Shareholder's Funds are valued at 11.23 Cr, and Total Assets amount to 25.17 Cr.

Read More

How has been the historical performance of Sharma E I Hosp.?

17-Nov-2025

Sharma E I Hosp. has shown significant growth in net sales and profits from Mar'21 to Mar'25, with net sales increasing from 8.13 Cr to 29.87 Cr. However, the company faced challenges with rising expenditures and cash flow volatility, impacting its operating profit.

Answer:<BR>The historical performance of Sharma E I Hosp. shows significant fluctuations in its financial metrics over the years.<BR><BR>Breakdown:<BR>Sharma E I Hosp. has experienced notable changes in its net sales, which increased from 8.13 Cr in Mar'21 to 29.87 Cr in Mar'25, reflecting a strong upward trend. The total operating income followed a similar trajectory, rising from 8.13 Cr in Mar'21 to 29.87 Cr in Mar'25. However, the company faced challenges with total expenditure, which also increased from 8.78 Cr in Mar'21 to 26.22 Cr in Mar'25. This led to an operating profit (PBDIT) that fluctuated, reaching 3.65 Cr in Mar'25 after a loss of 1.88 Cr in Mar'24. The profit before tax improved from 0.84 Cr in Mar'21 to 1.41 Cr in Mar'25, while profit after tax also saw an increase, rising from 0.64 Cr in Mar'21 to 1.24 Cr in Mar'25. The company's total assets grew from 16.29 Cr in Mar'18 to 27.67 Cr in Mar'25, indicating a solid asset base, while total liabilities increased from 16.29 Cr in Mar'18 to 27.67 Cr in Mar'25. Cash flow from operating activities showed volatility, with a negative cash flow of 1.00 Cr in Mar'24, but the company generated a positive cash flow from investing activities of 5.00 Cr in the same year. Overall, Sharma E I Hosp. has shown growth in sales and profits, despite facing challenges in managing expenses and cash flows.

Read More

Why is Sharma E I Hosp. falling/rising?

21-Dec-2025

As of N/A, Sharma East India Hosp and Medical Research Ltd's stock price is rising by 1.0% despite recent declines over the past week and month. Year-to-date, the stock has increased by 45.77%, indicating strong long-term performance.

As of N/A, Sharma East India Hosp and Medical Research Ltd's stock price is currently rising, as indicated by a change of 1.3, which represents a 1.0% increase. This upward movement occurs despite a recent decline in the stock's performance over the past week and month, where it has fallen by 3.76% and 1.53%, respectively. However, the year-to-date performance shows a significant increase of 45.77%, and over the past year, the stock has risen by 67.39%. These strong long-term gains suggest that the stock has been performing well overall, contributing to the current rise in price.

Read More

Why is Sharma E I Hosp. falling/rising?

23-Dec-2025

As of N/A, Sharma East India Hosp and Medical Research Ltd's stock price is 131.15, having increased by 1.0% today. Despite recent short-term declines, the stock has shown strong year-to-date growth of 45.11% and a 63.37% increase over the past year, indicating a positive long-term trend.

As of N/A, Sharma East India Hosp and Medical Research Ltd's stock price is currently at 131.15, reflecting an increase of 1.3 (1.0%). Despite this daily rise, the stock has shown a decline over the past week and month, with decreases of 1.65% and 2.82%, respectively. However, it is important to note that the stock has performed exceptionally well year-to-date, with a significant increase of 45.11%, and has risen by 63.37% over the past year. This strong long-term performance suggests that while there may be short-term fluctuations, the overall trend for the stock remains positive. The recent daily increase could be a response to market conditions or investor sentiment, but the lack of specific positive or negative factors in the provided data limits further analysis.

Read More

Why is Sharma East India Hosp and Medical Research Ltd falling/rising?

25-Dec-2025

As of N/A, Sharma East India Hosp and Medical Research Ltd's stock price is currently 146.00, reflecting a significant year-to-date increase of 61.54% and a 74.83% rise over the past year, indicating strong investor confidence and positive market sentiment.

As of N/A, Sharma East India Hosp and Medical Research Ltd's stock price is rising, currently at 146.00, reflecting a change of 8.55, or 6.22%. This upward movement can be attributed to several factors highlighted in the stock's performance metrics. Over the past week, the stock has increased by 5.80%, significantly outperforming the Sensex, which rose by only 1.00%. In the last month, the stock has shown a gain of 6.65%, again surpassing the Sensex's modest increase of 0.60%. <BR><BR>Year-to-date, the stock has experienced a remarkable rise of 61.54%, compared to the Sensex's 9.30%, and over the past year, it has surged by 74.83%, while the Sensex has only increased by 8.84%. These substantial gains indicate strong investor confidence and positive market sentiment towards Sharma East India Hosp and Medical Research Ltd, contributing to the stock's rising price.

Read More

Why is Sharma East India Hosp and Medical Research Ltd falling/rising?

25-Dec-2025

As of N/A, Sharma East India Hosp and Medical Research Ltd's stock price is currently 146.00, reflecting a 6.22% increase. The stock has shown strong growth over various periods, significantly outperforming the benchmark Sensex.

As of N/A, Sharma East India Hosp and Medical Research Ltd's stock price is rising, currently at 146.00, which reflects an increase of 8.55 or 6.22%. This upward movement is supported by the stock's performance over various periods, showing a 5.80% increase over the past week, a 6.65% rise over the past month, and a significant year-to-date increase of 61.54%. Additionally, the stock has appreciated by 74.83% over the past year, indicating strong overall growth compared to the benchmark Sensex, which has only increased by 9.30% in the same timeframe. The consistent outperformance of Sharma East India Hosp and Medical Research Ltd relative to the Sensex suggests positive investor sentiment and confidence in the company's prospects, contributing to the rise in its stock price.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Healthcare Services

stock-summary
Market cap

INR Cr ()

stock-summary
P/E

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.00

stock-summary
Return on Equity

0.00%

stock-summary
Price to Book

0.00

Revenue and Profits:
Net Sales:
9 Cr
(Quarterly Results - Sep 2025)
Net Profit:
0 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-20.1%
0%
-20.1%
6 Months
63.08%
0%
63.08%
1 Year
52.85%
0%
52.85%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Sharma E I Hosp. for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions
News

Why is Sharma East India Hosp and Medical Research Ltd falling/rising?

Recent Price Movement and Market Context

On the latest trading session, Sharma East India Hosp and Medical Research Ltd’s stock price decreased by ₹11.55, representing an 8.15% fall. Although the exact date and time of this price movement are not specified, the decline is significant in the context of the stock’s recent performance. Over the past week, the stock has shown a modest gain of 0.27%, slightly outperforming the Sensex’s 0.13% rise. However, over the last month, the stock has declined by 1.36%, which is a steeper fall compared to the Sensex’s 0.66% drop. This recent volatility suggests some short-term pressures on the stock despite its strong longer-term trajectory.

Strong Long-Term Performance Against Benchmark

Sharma East India Hosp ...

Read More
Announcements stock-summary

Board Meeting Outcome for Outcome Of Board Meeting Held On November 14 2025 Pursuant To Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.

14-Nov-2025 | Source : BSE

As per attachment.

Announcement under Regulation 30 (LODR)-Resignation of Director

14-Nov-2025 | Source : BSE

Resignation of Independent non-executive Director of the Company.

Intimation Of Reconstitution Of Audit Committee And Nomination And Remuneration Committee Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015

14-Nov-2025 | Source : BSE

As per attachment

Corporate Actions stock-summary
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors
Quality key factors stock-summary

No Data Found

Valuation key factors

No Data Found

Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Dow Theory
No Trend
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Sep'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is -0.95% vs 58.36% in Jun 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 0.00% vs -13.51% in Jun 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "9.38",
          "val2": "9.47",
          "chgp": "-0.95%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.93",
          "val2": "0.92",
          "chgp": "1.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.11",
          "chgp": "-9.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.32",
          "val2": "0.32",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "9.91%",
          "val2": "9.71%",
          "chgp": "0.20%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is 19.82% vs 44.80% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is 8.47% vs 51.28% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "18.86",
          "val2": "15.74",
          "chgp": "19.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.86",
          "val2": "1.98",
          "chgp": "-6.06%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.21",
          "val2": "0.42",
          "chgp": "-50.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.64",
          "val2": "0.59",
          "chgp": "8.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "9.86%",
          "val2": "12.58%",
          "chgp": "-2.72%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "23.89",
          "val2": "16.72",
          "chgp": "42.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2.84",
          "val2": "2.45",
          "chgp": "15.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.57",
          "val2": "0.81",
          "chgp": "-29.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.88",
          "val2": "0.62",
          "chgp": "41.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "11.89%",
          "val2": "14.65%",
          "chgp": "-2.76%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 61.29% vs -10.66% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 87.88% vs -20.48% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "29.87",
          "val2": "18.52",
          "chgp": "61.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3.65",
          "val2": "-1.88",
          "chgp": "294.15%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.72",
          "val2": "0.95",
          "chgp": "-24.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "1.24",
          "val2": "0.66",
          "chgp": "87.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "12.22%",
          "val2": "-10.15%",
          "chgp": "22.37%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Sep'25 - QoQstock-summary
Sep'25
Jun'25
Change(%)
Net Sales
9.38
9.47
-0.95%
Operating Profit (PBDIT) excl Other Income
0.93
0.92
1.09%
Interest
0.10
0.11
-9.09%
Exceptional Items
0.00
0.00
Standalone Net Profit
0.32
0.32
Operating Profit Margin (Excl OI)
9.91%
9.71%
0.20%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Sep 2025 is -0.95% vs 58.36% in Jun 2025

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Sep 2025 is 0.00% vs -13.51% in Jun 2025

Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary
Sep'25
Sep'24
Change(%)
Net Sales
18.86
15.74
19.82%
Operating Profit (PBDIT) excl Other Income
1.86
1.98
-6.06%
Interest
0.21
0.42
-50.00%
Exceptional Items
0.00
0.00
Standalone Net Profit
0.64
0.59
8.47%
Operating Profit Margin (Excl OI)
9.86%
12.58%
-2.72%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is 19.82% vs 44.80% in Sep 2024

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2025 is 8.47% vs 51.28% in Sep 2024

Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
23.89
16.72
42.88%
Operating Profit (PBDIT) excl Other Income
2.84
2.45
15.92%
Interest
0.57
0.81
-29.63%
Exceptional Items
0.00
0.00
Standalone Net Profit
0.88
0.62
41.94%
Operating Profit Margin (Excl OI)
11.89%
14.65%
-2.76%
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

Annual Results Snapshot (Standalone) - Mar'25stock-summary
Mar'25
Mar'24
Change(%)
Net Sales
29.87
18.52
61.29%
Operating Profit (PBDIT) excl Other Income
3.65
-1.88
294.15%
Interest
0.72
0.95
-24.21%
Exceptional Items
0.00
0.00
Standalone Net Profit
1.24
0.66
87.88%
Operating Profit Margin (Excl OI)
12.22%
-10.15%
22.37%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is 61.29% vs -10.66% in Mar 2024

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2025 is 87.88% vs -20.48% in Mar 2024

stock-summaryCompany CV
About Sharma East India Hosp and Medical Research Ltd stock-summary
stock-summary
Sharma East India Hosp and Medical Research Ltd
Healthcare Services
Sharma East India Hospitals & Medical Research Limited was incorporated on November 16, 1989. The Company is primarily engaged in providing medical and healthcare services and real estate services and is presently running a multi-specialty hospital in the name and style of 'Jaipur Hospital' at Lal Kothi, Jaipur, Rajasthan since 1989.
Company Coordinates stock-summary
Company Details
Jaipur Hospitals Lal Kothi, Near SMS Stadium Tonk Road Jaipur Rajasthan : 302015
stock-summary
Tel: 91-141-2742266/2741465/2741465
stock-summary
jaipurhospital_lalkothi@rediffmail.
Registrar Details
Beetal Financial & Computer Services (P) Ltd , Beetal House , 99 Mandangir, 3rd Floor, Behind Local Shopping Centre, Near Dada Harsukhdas Mandir, New Delhi